In North America, Syngenta has entered into an agreement with Gowan Company L.L.C., a family-owned agricultural solutions business headquartered in Yuma, Arizona. Gowan has been granted an exclusive license to market and sell a patented spiropidion 300 SC formulation in the United States and Canada.
“Spiropidion is the result of our commitment to bring two new and sustainable active ingredients to the market every year,” said Jeff Cecil, head of marketing, Syngenta Crop Protection, North America. “Its development also reflects our deep understanding and anticipation of grower needs. We are pleased to be collaborating with Gowan to deliver this solution to the market.”
Syngenta plans regulatory submissions for late 2022 in the U.S. and Canada and anticipates product launch by mid-decade. The first global registration of a formulated product containing spiropidion was obtained in Guatemala in September 2020. Over the next six years, product launches are expected in more than 60 countries.
Join the conversation online — connect with Syngenta at Syngenta-us.com/social.